X-Ray Detectors Market Projected to Reach $4.0 Billion by 2030
[London, United Kingdom] – [1st June 2023] – The global X-ray detectors market is projected to reach $4.0 billion by 2030, according to a new report by Pharmanucleus. The market is being driven by the increasing demand for X-ray imaging in a variety of applications, including medical, industrial, and security.
X-ray detectors are used to convert X-rays into electrical signals that can be used to create images. The market is segmented by technology, application, and region. By technology, the market is segmented into flat panel detectors and computed radiography (CR) detectors. Flat panel detectors are the fastest-growing segment of the market due to their advantages over CR detectors, such as higher image quality, faster image acquisition, and greater flexibility.
By application, the market is segmented into medical, industrial, and security. The medical segment is the largest segment of the market due to the increasing demand for X-ray imaging in a variety of medical procedures, such as bone density scans, dental X-rays, and chest X-rays.
By region, the market is segmented into North America, Europe, Asia Pacific, and Rest of the World (RoW). North America is the largest market for X-ray detectors due to the high prevalence of chronic diseases, such as cancer and heart disease, and the increasing demand for minimally invasive procedures.
The X-ray detectors market is facing some challenges, such as the high cost of X-ray imaging and the need for skilled operators to operate X-ray machines. However, the market is expected to continue to grow due to the increasing demand for X-ray imaging in a variety of applications.
For more information about the report and to request a sample copy, please visit
Contact Us:
John.M
Business Consultant
john.m@pharmanucleus.com
Support: +44 (0)20 8470 4967
https://www.pharmanucleus.com/
About Pharmanucleus
Pharma Nucleus is a market research company that provides clients access to custom, syndicated reports and consulting on one platform. As a company with rich knowledge in analysis and research across healthcare domains, such as pharma, medical device and biotechnology. Insights derived from Pharma Nucleus help life sciences and other healthcare organizations accelerate the launch, development, and dissemination of life-saving therapies, navigate significant attention with key opinion leaders, and help ensure equitable access to healthcare services.